GenomeScan

GenomeScan is a Netherlands-based provider of next-generation sequencing (NGS) services, headquartered in Leiden. The company positions itself as a partner in genetic research and diagnostics, offering genetic analysis for clinical and laboratory research. Its customer base spans the pharmaceutical industry, biotechnology and agricultural companies, healthcare providers and academic institutions — organisations whose work has an impact on healthcare and quality of life. GenomeScan leverages innovative NGS technologies to advance solutions from basic research through the preclinical stage to everyday clinical practice, with the stated aim of paving the way towards personalized medicine. The company describes its offer as tailored, end-to-end solutions. Its experienced team guides clients along every step: from designing the experimental setup, through sample preparation and full-stack reporting, to interpretation of the data, with a turnaround time that fits the customer's needs. GenomeScan emphasises four benefits of working with it: People, Experience, Innovation and Quality. Its team consists of scientists and technicians with diverse scientific backgrounds, whom clients can consider an extension of their own team, committed to providing excellent, robust and fast NGS services with matched bioinformatics solutions. The company cites a track record of nearly two decades in genetic services and strong support and shareholding of large Academic Medical Centers. It handles batched or single-sample processing, prospective or retrospective clinical cohorts, archive samples, biosafety testing material, plant and microbiome samples. On the innovation side, GenomeScan points to well-established contacts with technology providers, collaborations with academic researchers, and participation in numerous scientific consortia, which it says grant clients access to the most advanced sequencing methodologies and solutions. Quality is described as being of paramount importance, and the company operates under ISO/IEC 17025 accreditation (L518). It also references IVDR compliance, and states that personal data and privacy are secured via a data management system that guarantees protection in compliance with (inter)national requirements. GenomeScan organises its services around several application areas and business units. Its homepage highlights Diagnostics (NGS services with short turnaround times), Genetic QC (NGS-based genetic quality-control solutions), Microbiome (understanding the role of the microbiome in health and disease) and Oncology (using the power of NGS for patients and cancer research). Its academic research offering covers DNA sequencing — whole genome sequencing (WGS), whole exome sequencing (WES) and a Focused Inherited Disease Scan — as well as MicrobiomeScan, transcriptomics (total RNA, including messenger RNA and long non-coding RNA), epigenetics (methylation through Oxford Nanopore Technologies) and bioinformatics with custom data analysis and validated pipelines for all standard applications. Business units listed on the site include Genetic QC, Oncology and Neurology. GenomeScan presents itself as a service organisation rather than a product manufacturer, selling sequencing capacity, bioinformatics and scientific expertise to research and clinical customers. It maintains a blog and news section, publishes guidelines and resources, and recruits through a career opportunities page. The company also references EU and NL funded projects, underlining its embeddedness in the Dutch and European life-science ecosystem.

GenomeScan is a Netherlands-based genetic services company located in Leiden. Public information about the company is primarily available through its own website and a Wikidata entry identifying it as a company in Leiden, Netherlands. The company states that it has a track record of nearly two decades in genetic services, and elsewhere refers to over 15 years of experience in genetics, indicating that it was established in the first decade of the 2000s. It also notes strong support and shareholding of large Academic Medical Centers, which places its origins in the Dutch academic medical ecosystem. From its base in Leiden, GenomeScan built its business around next-generation sequencing (NGS) as the technology matured and became central to genetics research and clinical diagnostics. The company developed an end-to-end service model: designing experimental setups, preparing samples, running sequencing, providing full-stack reporting and interpreting data, with turnaround times adapted to client needs. It serves the pharmaceutical industry, biotechnology and agricultural companies, healthcare providers and academic institutions. Over time GenomeScan organised its activities into application areas and business units. Its website lists Diagnostics, Genetic QC, Microbiome and Oncology among its main service themes, and Genetic QC, Oncology and Neurology as business units. Its academic research offering includes DNA sequencing (whole genome sequencing, whole exome sequencing and a Focused Inherited Disease Scan), MicrobiomeScan, transcriptomics covering total RNA such as messenger RNA and long non-coding RNA, epigenetics with methylation analysis through Oxford Nanopore Technologies, and bioinformatics with custom data analysis and validated pipelines for standard applications. Quality and regulatory compliance have been central to the company's positioning. GenomeScan operates under ISO/IEC 17025 accreditation (L518) and references IVDR compliance, and it states that personal data and privacy are secured through a data management system compliant with (inter)national requirements. The company also highlights participation in numerous scientific consortia and EU and NL funded projects, as well as collaborations with academic facilities in the Netherlands and beyond, as sources of innovation and access to advanced sequencing methodologies. GenomeScan maintains a blog and news section and a career opportunities page, and it recruits scientists and technicians with diverse scientific backgrounds. Its customer-facing approach emphasises one-to-one scientific and technical support, publication-ready results and affordable experiments, positioning the company as an extension of its clients' own teams.

A Dutch NGS service provider and partner in genetic research and diagnostics, offering tailored, end-to-end sequencing and bioinformatics solutions with ISO/IEC 17025 accreditation and support from large Academic Medical Centers.

• Whole Genome Sequencing (WGS)

  DNA sequencing service covering the whole genome.

• Whole Exome Sequencing (WES)

  DNA sequencing service targeting the exome.

• Focused Inherited Disease Scan

  A focused DNA sequencing panel for inherited disease.

• MicrobiomeScan

  NGS-based microbiome analysis offering.

• Transcriptomics

  Total RNA analysis including messenger RNA and long non-coding RNA.

• Epigenetics

  Methylation analysis through Oxford Nanopore Technologies.

• Bioinformatics

  Custom data analysis and validated pipelines for all standard applications.

• Genetic QC

  Next Generation Sequencing-based genetic QC solutions.

• Oncology NGS

  NGS services for patients and cancer research.

• Diagnostics NGS

  NGS services with short turnaround times.

1. 1Customized NGS services | GenomeScangenomescan.nl
2. 2About GenomeScan NGS Services | GenomeScangenomescan.nl
3. 3Academic research NGS services | GenomeScangenomescan.nl
4. 4GenomeScan (Netherlands) - Wikidatawikidata.org